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Abstract
Objective. In order to identify the radiotherapy-induced histological modiﬁcations in the mesorectum, we reviewed the
surgical specimens of 90 rectal resections comprehensive of the total mesorectal excision (23 cases radiologically classiﬁed as
cT2N0M0 and 67 as cT3N0M0). All patients were preoperative treated with radiotherapy: 20 with 50 Gy, 20 with 20 Gy and
50 Gy irradiation associated to FOLFOX scheme chemotherapy. Material and methods. Routine hematoxylin and eosin
stained serial slides at 5 mm of intervals were obtained from surgical specimens and included the tumor site and the adjacent
irradiated mucosa, the submucosa and the muscular layers of the rectal wall and the mesorectal adipose tissue, completely
removed until to the mesorectal fascia. Ten subjects (eight cT2N0M0 and two cT3N0M0), who did not received preoperative
oncological treatments were adopted as controls.Results.Histologically, examination revealed ﬁbrosis of the adipose tissue in
86 cases (95%), vascular damage including vasculities and ﬁbrotic thickening wall of arteries and veins in 46 cases (51%),
sclero-hyalinosis of lymph nodes with pericapsular ﬁbrosis in 22 cases (23%) and perineural deposition of ﬁbrosis in 12 (13%).
These ﬁndings were ubiquitously observed in the whole mesorectum. Fibrosis of the adipose tissue and vasculitis were mainly
associated to the combination of 50 Gy radiations plus chemotherapy (p < 0.05). Conclusion. The detection of histopath-
ological alterations in the mesorectum can give reason of the well-known postoperative complications and long-term sequels.
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Introduction
The main interests of histopathological studies con-
cerning the mesorectum include its involvement by
the tumor masses as well as the presence of lymph
node metastasis and the impact of its surgical resec-
tion on the accuracy of the stadiation of the rectal
tumors [1–5]. On the other hand, the relevance of
neoajuvant radiotherapy in rectal cancer is well
known, as well as the post-treatment complications,
early and late clinical sequels [6–8]. The main pur-
pose of our study is to assess histological modiﬁca-
tions of the mesorectal anatomical components
induced by neoajuvant radiotherapy.
Methods
We reviewed the histological specimens of 90 surgi-
cally removed rectum for primary adenocarcinoma,
with total mesorectal excision after neoajuvant radio-
therapy, alone or in association with chemotherapy.
Cases were selected from a Specialized Colorectal
Cancer Registry instituted in 1984 in the Province
of Modena (Italy) in which clinical and pathological
informations about the tumors and its behavior were
meticulously scheduled [9,10]. Only tumors preop-
eratively classiﬁed as cT2N0M0 and cT3N0M0 at
computed tomography (CT) or magnetic resonance
(MR) were included in the study. For cT3 tumors, we
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considered those with only partial involvement of the
mesorectal adipose tissue (within 1 cm of maximum
depth) in order to keep out the possible histological
alterations associated to neoplastic regression (tumor
site) and not induced by radiotherapy. Cases with a
preoperative radiological signs of involvement of the
mesorectal fascia were excluded.
Based on the different schemes of preoperative
oncologic treatments, all 90 cases were subdivided
into 4 groups: group 1 that included 50 subjects
(2 cT2N0M0 and 48 cT3N0M0) who received a
50 Gray neoadjuvant radiation in association with
chemotherapeutic FOLFOX regimen, 6–8 weeks
before surgery; group 2 that regarded 20 patients
(8 cT2N0M0 and 12 cT3N0M0) treated with
50 Gray neoadjuvant radiation alone; group 3 that
concerned 20 patients (13 cT2N0M0 and
7 cT3N0M0) underwent to neoadjuvant radiotherapy
of 25 Gray followed by surgery alone within 10 days.
Ten subjects (eight cT2N0M0 and two cT3N0M0)
who did not receive preoperative oncological treat-
ments were used as control cases – group 4.
Slides stained with hematoxylin and eosin,
obtained from surgical specimens, ﬁxed in 10% buff-
ered formalin solution for 48 h and representative of
the whole tumor with the surrounding complete
excised mesorectum, were available for each cases
and carefully reviewed. All the specimens were sys-
tematically examined through serial sectionings on
the transversal side with a 5-mm interval. Slides
included the mucosa, submucosa and muscular layers
of the rectal wall and the mesorectal adipose tissue,
completely removed up to the mesorectal fascia. We
examined an average of 44 slides for each case (range
28–52 consecutive slides), following the procedure
described by Parﬁtt and colleagues [1].
The regression of the neoplastic masses was semi-
quantitatively determined by the amount of viable
tumors versus the amount of ﬁbrosis, ranging from
no evidence of any treatment effect to a complete
response with no more viable tumor identiﬁed
(Dworak’s system) [11]. Residual of the tumor
mass was staged using the TNM criteria [12].
The meticulous histological examination of the
mesorectum tissue focused on the evaluation of the
interstitial tissue, arterial, venous and lymphatic ves-
sels, nerves and lymph nodes.
Statistical analysis
Fisher exact test was applied to compare the categor-
ical variables. A probability (p) value less than
0.05 was considered statistically signiﬁcant for the
statistical analyses. Data were analyzed using the
SPSS package version 6.1.3 (SPSS Inc., Chicago,
IL, USA).
Ethical issue
The study has been performed according to the Dec-
laration of Helsinki and the study-design has been
approved by local ethics committee (RIF. PROTO-
COL. N. n 248/13 C.E. –October 29, 2013; Comitato
Etico della Provincia di Modena - Italy). The patients
were collected in anonymous ﬁle, and no clinical or
personal data were treated in the present study.
Results
Clinical and general histopathological features of the
studied cases (90 treated subjects and 10 controls) are
listed in Table I. In particular, the average patient’s
age at the moment of the diagnosis was 67 ±
11,23 years (56–84) and 69 ± 14,18 years (61–78),
respectively, in the two groups (cases and controls),
with no difference between males (52 subjects) and
females (48 subjects). Preoperative MR staging
showed 31 cT2N0M0 tumors (23 cases and 8 con-
trols) and 69 cT3N0M0 (67 cases and 2 controls). No
tumor regression (Dworak regression grade 0) was
observed in 25 cases represented by
23 ypT3NoM0 and 2 ypT2N0M0 tumors; a partial
tumor regression (Dworak regression grade 1, grade
2 and grade 3) was observed in 59 cases
(16 ypT2N0M0 and 43 ypT3N0M0). Complete
tumor regression (Dworak regression grade 4) was
graduated in six cases (ypT0N0M0). No metastatic
lymph nodes were histologically detected, and all the
surgical margins (mucosal and circumferential mesor-
ectal margins) were disease-free.
The mainly histological modiﬁcations of the mesor-
ectum induced by preoperative radiotherapy were
observed in the adipose tissue, in arterial, venous
and lymphatic vessels, in the nerves and lymph nodes
and are listed in Table II. The most evident features
were dense and compact ﬁbrotic strands connected
with the rectal fascia and with radial pattern of growth,
dislocated in the interstitial component of the mesor-
ectum. Although diffusely detected in the specimens
of 86/90 (95%) treated cases (Figure 1A), they were
mainly observed in the group 1 (50/50 subjects pre-
operatively treated with combination of 50 Gy plus
chemotherapy); differently only 1 of the 10 controls
showed mild and focal ﬁbrosis (p < 0.05). Fibrotic
bands were uniformly distributed in the total mesor-
ectum and were close to the ﬁbrous tissue replacing
tumor in the rectal wall. At times, the thickened bands
of ﬁbrosis developed a lobulation of the adipose tissue
(Figure 1B and 1C) entrapping lymph vascular
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structures and nerves (Figure 1D). Within the
lobules, an increase of ﬁbroblastic component was
clearly evident, with consequent mild reduction of the
adipocytes. A concomitant vascular damage was
observed in more than half of the treated cases (46/
90; 51%), mainly in the groups of the patients treated
with 50 Gy irradiation combined with chemotherapy –
Group 1 – (39/50 vs 4/20 and 2/20 subjects, respec-
tively, in the three groups p < 0.05). The arterial
network, represented by branches of small caliber,
showed thickening of the tunica media with an abun-
dant mixoid matrix deposition (Figure 2A and 2B),
and the intima was hyperplastic with narrowed lumen;
at times a micro-thrombosis was observed. Fibrosis
surrounding the wall of the arteriole (Figure 2C) and
pan-arteritis were clearly detected in more than half
cases (Figure 2D and 2E). In the adventitia of the
arteriole of 5 patients treated with chemotherapy in
association to radiotherapy, an inﬁltration of eosino-
phils was evident (Figure 2F). Similar alterations,
including a thickening of the wall with narrowing of
the lumen and associated micro-thrombus were
observed in small veins and in the lymphatic channels,
although in smaller quantities than what was observed
in the arteries. Occasional ﬁndings of complete oblit-
eration of the lumen induced by the ﬁbrosis were
observed in the lymphatic channels proximal to
tumor-growth margins. Only one of the controls
showed unspeciﬁc mild signs of inﬂammation asso-
ciated to mild edema and mild hyperemia. As
reported in Figure 3A and B, the lymph nodes showed
necrosis and sclerotic modiﬁcations with disruption of
the capsule. This ﬁnding occurred in 22 of the 90 trea-
ted patients (14 subjects in group 1, 5 in group 2 and
3 in group 3; 24%) but not in the control cases and
with no statistical difference between the three
groups. In 12/90 cases (13%), small nerves showed
discrete ﬁbrosis, at times associated to lymphoid and
plasma cells recruitment (Figure 3C and D). Stated
that the histopathological alterations described in our
study occurred in the whole mesorectum of the three
different treated groups, we failed to deﬁne a possible
grading score. Even if not statistically signiﬁcant, in
the cohort of 20 cases that underwent surgery within
2 weeks after 25 Gray short-term preoperative radio-
therapy, the ﬁbrosis was less intense and mild signs of
inﬂammation were detectable around lymph and vas-
cular vessels and nerves. We did not ﬁnd any signif-
icant correlation between the histological
modiﬁcations induced by chemoradiotherapy and
the Dworak’s score of tumor regression and the
preoperative c- or post-treatment y- parameters. In
the non-neoplastic rectal wall, we observed mucosal
damage that varied from erythematous changes to
Table I. Clinical and pathological features of the 90 preoperative irradiated patients and the 10 not treated controls.
Irradiated patients (90 patients) Not irradiated patients (10 patients)
Clinical and pathological features
Age at diagnosis 67 ± 11,23 years (56–84) 69 ± 14,18 years (61–78)
Male/female 46/44 6/4
Preoperative staging
uT2N0M0 23 8
uT3N0M0 67 2
Pathological staging
yT0N0M0 6 -
yT2N0M0 18 -
yT3N0M0 66 -
Regression-grade tumor (Dworak’s)
Dworak 0 25 -
Dworak 1-2-3 59 -
Dworak 4 6 -
Table II. Histopathological modiﬁcations observed in the 90 irradiated and 10 not treated patients.
Group 1
50 Gy+FOLFOX
(50 subjects)
Group 2
50 Gy (20 subjects)
Group 3
25 Gy (20 subjects)
Controls
(10 subjects) p-Value
Fibrous strands in the adipose tissue 50/50 17/20 19/20 1/10 < 0.05
Vascular damage* 39/50 4/20 3/20 1/10 < 0.05
Lymph node damage 14/50 5/20 3/20 None n.s.
Perineural deposition of ﬁbrosis 8/50 2/20 2/20 None n.s
*Includes vasculitis and thickening of the wall of arteries and veins.
Includes pericapsular ﬁbrosis and complete sclero-jalinosis.
n.s. = not statistically signiﬁcant.
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micro-ulcerations. In the submucosa, the interstitial
lymphoid-associated tissue was scanty or absent, and
the wall of the arterioles showed hyalinization and
increased thickness. Muscularis mucosae often
appeared distorted and replaced by ﬁbrosis.
Discussion
The use of radiation therapy for the cure of cancer
involves exposure of the surrounding normal tissue
inducing different modiﬁcations that vary during the
course of the treatment [13–15]. Our study represents
a morphological description of the histologic altera-
tions induced in the mesorectum by neoajuvant radio-
therapy, alone or associated with chemotherapy. In
particular, we focused on the different anatomical
components of the mesorectum including adipose
tissue, vascular supply and nerves localized external
to the tumor site. The most visible histological ﬁnd-
ings were represented by ﬁbrosis of the adipose tissue,
perivascular and perineural ﬁbrosis deposition, vas-
cular damage, revisable in vasculitis or micro-
thrombosis and sclero-hyalinosis of lymph nodes.
Although these histopathological ﬁndings had been
described in the literature as consequences of the
A
C D
B
Figure 1. Dense and compact ﬁbrous strands are dislocated in the
interstitial component of the irradiated mesorectum (A). At time,
thick bands developed a lobulation of the adipose tissue (B and C)
and entrapped lymph vascular structures and nerves (D).
A B
C D
E F
Figure 2. Vascular damage induced by radiotherapy. Thickened tunica media of arteries (A), with presence of myxoid matrix and histiocytes
(B) was observed in more than half cases. A perivascular ﬁbrosis surrounding the wall of the arteriole (C) and vasculitis were mainly observed in
subjects received neoajuvant chemoradiotherapy (D and E); eosinophils recruitment can be appreciated (F).
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irradiation of the pelvic region for different malignan-
cies including prostatic, gynecological or rectal cancer
[13], no detailed descriptions have been published
about them. In our experience, the whole evaluation
of the mesorectum tissue, performed through conse-
cutive cut sections, allowed us to establish that these
modiﬁcations were homogeneously distributed in all
mesorectum, up to the resected surgical margin. This
data is supported by previous studies that evaluated
the development of post-chemoradiotherapy ﬁbrotic
spiculations in the mesorectum, using the MR [16].
In literature, diffused hypointense ﬁbrotic tissue pro-
jecting the mesorectal fascia is reported in more than
50% of the patients [16]. Although the tangible
occurrence of these histological alterations of the
mesorectal components demonstrate the actual con-
sequence of the irradiation, it is important to state that
their interpretation should be done with caution. In
particular, it could be important to consider the time
span between the radiotherapy and the mesorectal
resection and the possible correlation with it [16,17].
In this period, a continuous remodeling process
occurs in the tissue with subsequent changes in the
cellular and extracellular microenvironments. These
changes could lead the pathologist to overestimate
them. In our study, we focused the attention on the
part of the mesorectum distant from the tumor site
being, this last, more susceptible to restore, in order to
exclude the histological modiﬁcation induced by the
necrotic tumoral tissue replaced by ﬁbrosis (post-
treatment scar). It is well known that in the irradiated
tissue, the histopathological changes are dose-related,
occur immediately after the radiation exposure and
are visible in weeks, months or even years after
treatment [13,17–22]. In our cases, the mesorectum
treated with high doses of radiotherapy (50 Gy)
showed diffuse and intense ﬁbrosis and vascular dam-
age, becoming more evident, whereas radiotherapy
was associated with chemotherapy. Thus, the altera-
tions could be the result of the combination of both
treatments [18].
The pathways underlying the abnormalities occur-
ring in the irradiated mesorectum reﬂect the effect of
the radiolysis on the immunological system, explicat-
ing in particular in the activation of the leukocytes,
most probably, through the release of the cytokines
[13,18,22–24]. The accumulation of inﬂammatory
cells, particularly evident in the perivascular recruit-
ment of lymphocytes and eosinophils, and in the
activation of ﬁbroblasts in the connective tissue, has
been demonstrated in patients treated with radiother-
apy [22–24]. In our study, mainly in the cases who
received radiotherapy plus chemotherapy, we
observed accumulation of inﬂammatory cells around
the vessel and the nerves composed by lymphocytes,
plasma cells and eosinophils. As a consequence of the
inﬂammation, the deposition of collagen and the
increase of extracellular matrix substance and a remo-
deling processes that lead to ﬁbrotic strands in the
adipose tissue and the myxoid thickening of the arte-
rial walls [18,22–24]. Some authors, using animal
models, evaluated the chronic macro- and micro-
effects of the irradiation in the tissue and described
particularly a vascular damage with degeneration of
the vessel wall, dilated capillaries and reduction in
their density [17,24]. Moreover, some studies have
demonstrated that normal lymphatic tissue as well as
metastatic lymph nodes are reduced by irradiation
[25,26] and that doses higher than 25 Gy are required
to cause damage to the peripheral nerves [16,17]. In
our study, we considered only previously deﬁned
N0-tumors by CT or MRI, and histologically con-
ﬁrmed to be macro- or micro-metastatic-free tumors.
Furthermore, we observed an overall reduction of the
lymphoid component in the mesorectum conﬁrming
the involution process of lymph nodes induced by the
therapy [13,16,25,26]. As reported in literature, high-
dose radiotherapy induces lymphocyte depletion,
atrophy of the stroma and adipocytes replacement,
leading to unrecognizable lymph nodes during histo-
logical examination of the mesorectum samples [26].
Based on our histological evidences, it can be
argued that the other pelvic structures, like the resid-
ual rectal stump, the anal canal, as well as the sphinc-
ter muscular apparatus, could also be affected by the
same modiﬁcations described in the mesorectum.
This could explain the well-known incidence of the
postsurgical clinical complications that are observed
at short- and long-term sequels. In particular, the
A B
C D
Figure 3. Lymph nodes pericapsular ﬁbrosis and complete sclero-
hyalinosis (A and B) and perineural deposition of ﬁbrosis (C and D)
were observed within the mesorectum adipose tissue, mainly in
subjects treated 50 Gy dose radiotherapy associated with
chemotherapy.
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vascular damage can lead to anastomotic ﬁstulas, the
ﬁbrosis can induce strictures, while the perineural
ﬁbrosis could give reason for the sphincter functional
disorders [13,27–29]. Concerning the importance of
the complete mesorectal excision, the pathological
modiﬁcations observed ubiquitously in the mesorec-
tum could reinforce the importance of this surgical
approach.
Concluding, our observations represent the mor-
phological description of the histopathological altera-
tions induced by adjuvant radiotherapy in the
different mesorectal anatomical components.
Although with limitations, they could give some pos-
sible explanations among their possible clinical rele-
vance including post-operative complications and
sequels.
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